Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L Mackie

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Nature Reviews. Rheumatology|March 19, 2014
Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCASarah L Mackie, Bhaskar Dasgupta
Rheumatology (Oxford, England)|January 30, 2020
What can negative temporal artery biopsies tell us?Sarah L Mackie, Elisabeth Brouwer
The Lancet. Rheumatology|January 22, 2024
Tocilizumab and glucocorticoids for giant cell arteritis: the learning curveSarah L Mackie, Rayna Bhogal
The Lancet. Rheumatology|January 22, 2024
Game-changing therapies for people with giant cell arteritis?Thurkka Rajeswaran, Sarah L Mackie
Annals of the Rheumatic Diseases|January 29, 2016
Response to: 'A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?' by Yang et alSarah L Mackie, Dennis G McGonagle
Practical Neurology|July 3, 2020
British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritisSusan P Mollan, Sarah L Mackie
BMJ (Clinical Research Ed.)|December 5, 2013
Polymyalgia rheumaticaSarah L Mackie, Christian D Mallen
Rheumatology (Oxford, England)|May 28, 2025
The safety of low-dose methotrexate for rheumatic diseases: looking beyond blood monitoringSarah L Mackie, Catherine L Hill
Rheumatology Advances in Practice|May 10, 2024
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatmentVanessa Quick, Fran Benson, Sarah L Mackie
Rheumatology (Oxford, England)|January 25, 2021
Why clinicians should know about Mendelian randomizationSizheng Steven Zhao, Sarah L Mackie, Jie Zheng
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Nature Reviews. Rheumatology|March 19, 2014
Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCASarah L Mackie, Bhaskar Dasgupta
Rheumatology (Oxford, England)|January 30, 2020
What can negative temporal artery biopsies tell us?Sarah L Mackie, Elisabeth Brouwer
The Lancet. Rheumatology|January 22, 2024
Tocilizumab and glucocorticoids for giant cell arteritis: the learning curveSarah L Mackie, Rayna Bhogal
The Lancet. Rheumatology|January 22, 2024
Game-changing therapies for people with giant cell arteritis?Thurkka Rajeswaran, Sarah L Mackie
Annals of the Rheumatic Diseases|January 29, 2016
Response to: 'A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?' by Yang et alSarah L Mackie, Dennis G McGonagle
Practical Neurology|July 3, 2020
British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritisSusan P Mollan, Sarah L Mackie
BMJ (Clinical Research Ed.)|December 5, 2013
Polymyalgia rheumaticaSarah L Mackie, Christian D Mallen
Rheumatology (Oxford, England)|May 28, 2025
The safety of low-dose methotrexate for rheumatic diseases: looking beyond blood monitoringSarah L Mackie, Catherine L Hill
Rheumatology Advances in Practice|May 10, 2024
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatmentVanessa Quick, Fran Benson, Sarah L Mackie
Rheumatology (Oxford, England)|January 25, 2021
Why clinicians should know about Mendelian randomizationSizheng Steven Zhao, Sarah L Mackie, Jie Zheng
Pageof 12